Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.30 |
| ▸ | CA4 | P22748 | 2/20 | 0.30 |
| ▸ | CA5A | P35218 | 2/20 | 0.30 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL690179 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL8206391 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL3370387 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL9272969 | 1.00 | SLC34A1 (0.58) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL8207716 | 1.00 | SLC34A1 (0.58) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL11118982 | 0.95 | SLC34A1 (0.54) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL28820294 | 0.95 | SLC34A1 (0.54) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL28799350 | 0.95 | SLC34A1 (0.54) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL158962 | 0.95 | SLC34A1 (0.54) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL7871824 | 0.95 | SLC34A1 (0.54) | SLC34A1LMNAKDM4ECYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116986565-A | Preparation method of anhydrous magnesium hydrogen phosphate | 江苏瑞丰医药有限公司 | 2023-11-03 | — | — | CN | disclosed |
| CN-114314540-A | Method for producing magnesium hydrogen phosphate by using phosphate tailings | 中国地质科学院矿产综合利用研究所 | 2022-04-12 | — | — | CN | disclosed |
| EP-2362871-B1 | ENHANCED STABILITY PERACID COMPOSITIONS | ECOLAB USA INC (US) | 2019-03-27 | — | — | EP | disclosed |
| CN-105645368-A | Synthetic process for magnesium hydrogen phosphate heptahydrate with combined production of calcium hydroxide and sodium chloride | 青岛首泰农业科技有限公司 | 2016-06-08 | — | — | CN | disclosed |
| CN-105645368-A | Synthetic process for magnesium hydrogen phosphate heptahydrate with combined production of calcium hydroxide and sodium chloride | 青岛首泰农业科技有限公司 | 2016-06-08 | — | — | CN | disclosed |
| CN-105584997-A | Method for producing magnesium hydrogen phosphate Heptahydrate by using boron mud | CHANGDE YUNGANG BIOTECHNOLOGY CO LTD | 2016-05-18 | — | — | CN | disclosed |
| CN-105584997-A | Method for producing magnesium hydrogen phosphate Heptahydrate by using boron mud | CHANGDE YUNGANG BIOTECHNOLOGY CO LTD | 2016-05-18 | — | — | CN | disclosed |
| US-8568613-B2 | Enhanced stability peracid compositions | ECOLAB USA INC. (US) | 2013-10-29 | — | — | US | disclosed |
| US-20110319489-A1 | ENHANCED STABILITY PERACID COMPOSITIONS | ECOLAB USA INC. (US) | 2011-12-29 | — | — | US | disclosed |
| CN-102219199-A | Method for preparing magnesium hydrogen phosphate heptahydrate and co-producing calcium hydroxide and sodium chloride by using boric sludge | JIAXING WANG | 2011-10-19 | — | — | CN | disclosed |
| CN-102219199-A | Method for preparing magnesium hydrogen phosphate heptahydrate and co-producing calcium hydroxide and sodium chloride by using boric sludge | JIAXING WANG | 2011-10-19 | — | — | CN | disclosed |
| US-8034759-B2 | Enhanced stability peracid compositions | ECOLAB USA INC. (US) | 2011-10-11 | — | — | US | disclosed |
| EP-2362871-A2 | ENHANCED STABILITY PERACID COMPOSITIONS | Ecolab INC. (US) | 2011-09-07 | — | — | EP | disclosed |
| US-20100108942-A1 | ENHANCED STABILITY PERACID COMPOSITIONS | ECOLAB INC. (US) | 2010-05-06 | — | — | US | disclosed |
| WO-2010049892-A2 | ENHANCED STABILITY PERACID COMPOSITIONS | ECOLAB INC. (US) | 2010-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319489-A1 | ENHANCED STABILITY PERACID COMPOSITIONS | SLC39A14, SLC30A5, SLC39A7 | SLC34A1 12/4885LMNA 1977/4885KDM4E 2055/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.